Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000807351 | SCV000947399 | uncertain significance | Charcot-Marie-Tooth disease, type 2 | 2018-10-05 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine with arginine at codon 102 of the AARS protein (p.Gly102Arg). The glycine residue is highly conserved and there is a moderate physicochemical difference between glycine and arginine. This variant is not present in population databases (ExAC no frequency). This variant has been observed to segregate with Charcot-Marie-Tooth disease in a family (PMID: 25904691), and in an unrelated individual with neuropathy and hyperreflexia (PMID: 26032230). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C15"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Inherited Neuropathy Consortium | RCV001027508 | SCV001190083 | uncertain significance | Charcot-Marie-Tooth disease | no assertion criteria provided | literature only |